PHARMACOKINETICS OF HALOPERIDOL IN PSYCHOTIC-PATIENTS

被引：44

作者：

CHENG, YF

PAALZOW, LK

BONDESSON, U

EKBLOM, B

ERIKSSON, K

ERIKSSON, SO

LINDBERG, A

LINDSTROM, L

机构：

[1] UNIV UPPSALA,DEPT BIOPHARMACEUT & PHARMACOKINET,BOX 580,S-75123 UPPSALA,SWEDEN

[2] ULLERAKER HOSP,HOSP PHARM,S-75017 UPPSALA,SWEDEN

来源：

PSYCHOPHARMACOLOGY | 1987年 / 91卷 / 04期

关键词：

D O I：

10.1007/BF00216005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：410 / 414

页数：5

相关论文

共 15 条

[1] BENET LZ, 1984, EUR J RESPIR DIS, V65, P45
[2] PLASMA-LEVEL PROFILE OF HALOPERIDOL IN MAN FOLLOWING INTRAMUSCULAR ADMINISTRATION
CRESSMAN, WA
BIANCHINE, JR
SLOTNICK, VB
JOHNSON, PC
PLOSTNIEKS, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) : 99 - 103
[3] PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY
DAHL, SG
[J]. CLINICAL PHARMACOKINETICS, 1986, 11 (01) : 36 - 61
[4] FORSMAN A, 1977, CURR THER RES CLIN E, V21, P245
[5] FORSMAN A, 1978, CURR THER RES CLIN E, V24, P567
[6] FORSMAN A, 1976, CURR THER RES CLIN E, V20, P319
[7] FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396
[8] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS
FORSMAN, A
MARTENSSON, E
NYBERG, G
OHMAN, R
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) : 113 - 124
[9] FACTORS AFFECTING DRUG METABOLISM
GILLETTE, JR
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 43 - &
[10] HALOPERIDOL KINETICS AFTER ORAL AND INTRAVENOUS DOSES
HOLLEY, FO
MAGLIOZZI, JR
STANSKI, DR
LOMBROZO, L
HOLLISTER, LE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) : 477 - 484